More clinical trials on the direct and indirect effects of GLP-1s and their mechanisms of action are needed. As the body of research expands on the potential of glucagon-like peptide-1 receptor ...

Beyond weight loss: protecting muscle with GLP-1s. Dr Almandoz shares strategies to preserve muscle, optimize body composition, and enhance health outcomes during GLP-1 therapy.

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

SALT LAKE CITY - LifeVantage Corporation (NASDAQ:LFVN), a $271 million market cap player in the health and wellness sector with impressive 79% gross profit margins, today announced the successful ...

There's a growing body of evidence that gold nanoparticles can offer significant, targeted weight loss that focuses on fat ...

The discovery, of course, goes beyond those taking GLP-1 medications. And while the BCL6 discovery came through a study on mice, researchers are confident it will translate to human physiology.

12-week chronic study GLP-1-H24-4 (the "Study") underway in Australia. Lexaria has completed its submission to the human research ethics committee ("HREC") for its planned addition of Study Arm 5 ...